Do analysts recommend SSII or SLNO?

Soleno Therapeutics has a consensus target price of $76.67, suggesting a potential upside of 44.63%. Given Soleno Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Soleno Therapeutics is more favorable than SS Innovations International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Soleno Therapeutics 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08

Do analysts rate WRBY or SSII?

Warby Parker currently has a consensus target price of $29.50, suggesting a potential upside of 20.75%. Given Warby Parker's stronger consensus rating and higher probable upside, equities research analysts plainly believe Warby Parker is more favorable than SS Innovations International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.64 SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend SSII or TMDX?

TransMedics Group has a consensus price target of $134.00, suggesting a potential upside of 98.43%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts plainly believe TransMedics Group is more favorable than SS Innovations International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 TransMedics Group 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.46

Do analysts recommend LMAT or SSII?

LeMaitre Vascular currently has a consensus price target of $112.60, indicating a potential upside of 23.17%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than SS Innovations International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LeMaitre Vascular 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SSII or AXGN?

AxoGen has a consensus target price of $46.50, indicating a potential upside of 20.09%. Given AxoGen's stronger consensus rating and higher possible upside, analysts clearly believe AxoGen is more favorable than SS Innovations International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SS Innovations International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AxoGen 2 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.64

SS Innovations International (SSII) Competitors

$3.94 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$3.93 -0.01 (-0.25%)

As of 07:45 PM Eastern

Compare

SSII vs. SLNO, WRBY, TMDX, LMAT, and AXGN

Should you buy SS Innovations International stock or one of its competitors? MarketBeat compares SS Innovations International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SS Innovations International include Soleno Therapeutics (SLNO), Warby Parker (WRBY), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry.

How does SS Innovations International compare to Soleno Therapeutics?

SS Innovations International (NASDAQ:SSII) and Soleno Therapeutics (NASDAQ:SLNO) are both medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Soleno Therapeutics has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	18.56	-$12.13M	-$0.05	N/A
Soleno Therapeutics	$285.01M	9.69	$20.89M	$1.77	29.95

In the previous week, SS Innovations International and SS Innovations International both had 1 articles in the media. SS Innovations International's average media sentiment score of 1.89 beat Soleno Therapeutics' score of 0.94 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Overall Sentiment
SS Innovations International	Very Positive
Soleno Therapeutics	Positive

Soleno Therapeutics has a consensus target price of $76.67, suggesting a potential upside of 44.63%. Given Soleno Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Soleno Therapeutics is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Soleno Therapeutics	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08

SS Innovations International has a beta of -1.89, meaning that its stock price is 289% less volatile than the broader market. Comparatively, Soleno Therapeutics has a beta of -2.22, meaning that its stock price is 322% less volatile than the broader market.

97.4% of Soleno Therapeutics shares are owned by institutional investors. 6.4% of Soleno Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Soleno Therapeutics has a net margin of 33.70% compared to SS Innovations International's net margin of -20.69%. Soleno Therapeutics' return on equity of 22.85% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
Soleno Therapeutics	33.70%	22.85%	18.25%

Summary

Soleno Therapeutics beats SS Innovations International on 12 of the 15 factors compared between the two stocks.

How does SS Innovations International compare to Warby Parker?

Warby Parker (NYSE:WRBY) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

93.2% of Warby Parker shares are held by institutional investors. 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Warby Parker currently has a consensus target price of $29.50, suggesting a potential upside of 20.75%. Given Warby Parker's stronger consensus rating and higher probable upside, equities research analysts plainly believe Warby Parker is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Warby Parker has a beta of 1.96, meaning that its stock price is 96% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.89, meaning that its stock price is 289% less volatile than the broader market.

Warby Parker has a net margin of 0.15% compared to SS Innovations International's net margin of -20.69%. Warby Parker's return on equity of 2.30% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
SS Innovations International	-20.69%	-23.00%	-13.18%

Warby Parker has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$871.91M	3.00	$1.64M	$0.02	1,221.50
SS Innovations International	$42.49M	18.56	-$12.13M	-$0.05	N/A

In the previous week, Warby Parker had 4 more articles in the media than SS Innovations International. MarketBeat recorded 5 mentions for Warby Parker and 1 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.89 beat Warby Parker's score of 1.14 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Overall Sentiment
Warby Parker	Positive
SS Innovations International	Very Positive

Summary

Warby Parker beats SS Innovations International on 14 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to TransMedics Group?

SS Innovations International (NASDAQ:SSII) and TransMedics Group (NASDAQ:TMDX) are both medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

TransMedics Group has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	18.56	-$12.13M	-$0.05	N/A
TransMedics Group	$605.49M	3.85	$190.29M	$4.40	15.35

TransMedics Group has a net margin of 27.04% compared to SS Innovations International's net margin of -20.69%. TransMedics Group's return on equity of 22.38% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
TransMedics Group	27.04%	22.38%	8.46%

99.7% of TransMedics Group shares are held by institutional investors. 6.9% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

SS Innovations International has a beta of -1.89, indicating that its stock price is 289% less volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market.

In the previous week, TransMedics Group had 2 more articles in the media than SS Innovations International. MarketBeat recorded 3 mentions for TransMedics Group and 1 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.89 beat TransMedics Group's score of 0.42 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Overall Sentiment
SS Innovations International	Very Positive
TransMedics Group	Neutral

TransMedics Group has a consensus price target of $134.00, suggesting a potential upside of 98.43%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts plainly believe TransMedics Group is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Summary

TransMedics Group beats SS Innovations International on 14 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

84.6% of LeMaitre Vascular shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

LeMaitre Vascular has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	8.37	$57.73M	$2.71	33.73
SS Innovations International	$42.49M	18.56	-$12.13M	-$0.05	N/A

In the previous week, LeMaitre Vascular had 1 more articles in the media than SS Innovations International. MarketBeat recorded 2 mentions for LeMaitre Vascular and 1 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.89 beat LeMaitre Vascular's score of 1.39 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Overall Sentiment
LeMaitre Vascular	Positive
SS Innovations International	Very Positive

LeMaitre Vascular has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.89, suggesting that its stock price is 289% less volatile than the broader market.

LeMaitre Vascular has a net margin of 24.35% compared to SS Innovations International's net margin of -20.69%. LeMaitre Vascular's return on equity of 15.36% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	24.35%	15.36%	9.78%
SS Innovations International	-20.69%	-23.00%	-13.18%

LeMaitre Vascular currently has a consensus price target of $112.60, indicating a potential upside of 23.17%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

LeMaitre Vascular beats SS Innovations International on 15 of the 17 factors compared between the two stocks.

How does SS Innovations International compare to AxoGen?

SS Innovations International (NASDAQ:SSII) and AxoGen (NASDAQ:AXGN) are both medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

AxoGen has a consensus target price of $46.50, indicating a potential upside of 20.09%. Given AxoGen's stronger consensus rating and higher possible upside, analysts clearly believe AxoGen is more favorable than SS Innovations International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AxoGen	2 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64

In the previous week, AxoGen had 1 more articles in the media than SS Innovations International. MarketBeat recorded 2 mentions for AxoGen and 1 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.89 beat AxoGen's score of 1.74 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Overall Sentiment
SS Innovations International	Very Positive
AxoGen	Very Positive

AxoGen has a net margin of -13.21% compared to SS Innovations International's net margin of -20.69%. AxoGen's return on equity of -9.63% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-20.69%	-23.00%	-13.18%
AxoGen	-13.21%	-9.63%	-6.26%

SS Innovations International has higher earnings, but lower revenue than AxoGen. SS Innovations International is trading at a lower price-to-earnings ratio than AxoGen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	18.56	-$12.13M	-$0.05	N/A
AxoGen	$238.11M	8.65	-$15.70M	-$0.64	N/A

SS Innovations International has a beta of -1.89, meaning that its share price is 289% less volatile than the broader market. Comparatively, AxoGen has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

80.3% of AxoGen shares are owned by institutional investors. 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

AxoGen beats SS Innovations International on 12 of the 16 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSII vs. The Competition

Export

Metric	SS Innovations International	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$788.52M	$4.21B	$6.72B	$12.56B
Dividend Yield	N/A	2.02%	3.01%	5.30%
P/E Ratio	-78.80	47.78	30.04	26.62
Price / Sales	18.56	52.45	424.49	114.14
Price / Cash	N/A	39.46	23.12	37.60
Price / Book	19.70	5.12	6.04	6.88
Net Income	-$12.13M	$31.79M	$204.03M	$336.73M
7 Day Performance	1.29%	9.86%	7.14%	4.19%
1 Month Performance	N/A	N/A	-13.65%	-0.08%
1 Year Performance	-35.09%	43.38%	43.21%	40.26%

SS Innovations International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSII SS Innovations International	1.2066 of 5 stars	$3.94 flat	N/A	-35.1%	$788.52M	$42.49M	N/A	4	Positive News
SLNO Soleno Therapeutics	4.3005 of 5 stars	$53.01 flat	$76.67 +44.6%	N/A	$2.76B	$285.01M	29.95	30
WRBY Warby Parker	4.2404 of 5 stars	$25.10 +2.4%	$29.50 +17.5%	+15.8%	$2.62B	$871.91M	1,255.63	4,036	Positive News
TMDX TransMedics Group	4.6145 of 5 stars	$68.93 +0.1%	$135.00 +95.9%	-47.5%	$2.38B	$605.49M	15.67	210
LMAT LeMaitre Vascular	4.8885 of 5 stars	$97.75 -1.8%	$112.60 +15.2%	+15.2%	$2.27B	$249.60M	36.07	490	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSII) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SS Innovations International (SSII) Competitors

SSII vs. SLNO, WRBY, TMDX, LMAT, and AXGN

How does SS Innovations International compare to Soleno Therapeutics?

Summary

How does SS Innovations International compare to Warby Parker?

Summary

How does SS Innovations International compare to TransMedics Group?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Summary

How does SS Innovations International compare to AxoGen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SS Innovations International (SSII) Competitors

SSII vs. SLNO, WRBY, TMDX, LMAT, and AXGN

How does SS Innovations International compare to Soleno Therapeutics?

Which has stronger earnings & valuation, SSII or SLNO?

Does the media prefer SSII or SLNO?

Do analysts recommend SSII or SLNO?

Which has more volatility & risk, SSII or SLNO?

Do insiders & institutionals hold more shares of SSII or SLNO?

Is SSII or SLNO more profitable?

Summary

How does SS Innovations International compare to Warby Parker?

Do institutionals and insiders have more ownership in WRBY or SSII?

Do analysts rate WRBY or SSII?

Which has more risk & volatility, WRBY or SSII?

Is WRBY or SSII more profitable?

Which has stronger earnings & valuation, WRBY or SSII?

Does the media prefer WRBY or SSII?

Summary

How does SS Innovations International compare to TransMedics Group?

Which has higher earnings & valuation, SSII or TMDX?

Is SSII or TMDX more profitable?

Do institutionals & insiders hold more shares of SSII or TMDX?

Which has more risk and volatility, SSII or TMDX?

Does the media favor SSII or TMDX?

Do analysts recommend SSII or TMDX?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Do insiders and institutionals have more ownership in LMAT or SSII?

Which has preferable valuation and earnings, LMAT or SSII?

Does the media refer more to LMAT or SSII?

Which has more risk & volatility, LMAT or SSII?

Is LMAT or SSII more profitable?

Do analysts recommend LMAT or SSII?

Summary

How does SS Innovations International compare to AxoGen?

Do analysts rate SSII or AXGN?

Does the media prefer SSII or AXGN?

Is SSII or AXGN more profitable?

Which has preferable earnings & valuation, SSII or AXGN?

Which has more risk and volatility, SSII or AXGN?

Do institutionals and insiders have more ownership in SSII or AXGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools